Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cyc065
1. Cyc065
2. 1070790-89-4
3. Cyc-065
4. Fadraciclib
5. Cyc065
6. Yet2xnu791
7. (2r,3s)-3-((6-(((4,6-dimethylpyridin-3-yl)methyl)amino)-9-isopropyl-9h-purin-2-yl)amino)pentan-2-ol
8. 1070790-89-4 (free Base)
9. (2r,3s)-3-[[6-[(4,6-dimethylpyridin-3-yl)methylamino]-9-propan-2-ylpurin-2-yl]amino]pentan-2-ol
10. 2-pentanol, 3-((6-(((4,6-dimethyl-3-pyridinyl)methyl)amino)-9-(1-methylethyl)-9h-purin-2-yl)amino)-, (2r,3s)-
11. Cyc065 Free Base
12. Cyc-065 Free Base
13. Fadraciclib [inn]
14. Unii-yet2xnu791
15. Fadraciclib [who-dd]
16. Chembl3655762
17. Schembl13300946
18. Gtpl10461
19. Bdbm106950
20. Bcp19571
21. Ex-a2830
22. Nsc806387
23. Cs-7615
24. Db15425
25. Nsc-806387
26. Ac-31595
27. Bc175840
28. Hy-101212
29. Us8592581, 1
30. A903453
| Molecular Weight | 397.5 g/mol |
|---|---|
| Molecular Formula | C21H31N7O |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 397.25900864 g/mol |
| Monoisotopic Mass | 397.25900864 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 507 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Fadraciclib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fadraciclib, including repackagers and relabelers. The FDA regulates Fadraciclib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fadraciclib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fadraciclib supplier is an individual or a company that provides Fadraciclib active pharmaceutical ingredient (API) or Fadraciclib finished formulations upon request. The Fadraciclib suppliers may include Fadraciclib API manufacturers, exporters, distributors and traders.
Fadraciclib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fadraciclib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fadraciclib GMP manufacturer or Fadraciclib GMP API supplier for your needs.
A Fadraciclib CoA (Certificate of Analysis) is a formal document that attests to Fadraciclib's compliance with Fadraciclib specifications and serves as a tool for batch-level quality control.
Fadraciclib CoA mostly includes findings from lab analyses of a specific batch. For each Fadraciclib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fadraciclib may be tested according to a variety of international standards, such as European Pharmacopoeia (Fadraciclib EP), Fadraciclib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fadraciclib USP).
LOOKING FOR A SUPPLIER?
